Health Products

Xolair (2019-09-06)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II

Summary

Product

Xolair

Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDIN, NPN, DIN-HIMDosage formStrength
SR532
Recalling Firm
Novartis Pharmaceuticals Canada Inc.
2476 Argentia Road, Unit 404
Mississauga
L5N 6M1
Ontario
CANADA
Marketing Authorization Holder
Novartis Pharmaceuticals Canada Inc.
385 Bouchard Boulevard
Dorval
H9S 1A9
Quebec
CANADA
XolairDIN 02260565Powder For Solution Omalizumab 150mg/Vial

Reason

Affected lot may contain the presence of silicone oil.

Depth of distribution

Retailers
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime